[1]
|
Diamantidis, M.D., Papaioannou, M. and Hatjiharissi, E. (2021) Primary Gastric Non-Hodgkin Lymphomas: Recent Advances Regarding Disease Pathogenesis and Treatment. World Journal Gastroenterology, 27, 5932-5945.
https://doi.org/10.3748/wjg.v27.i35.5932
|
[2]
|
Psyrri, A., Papageorgiou, S. and Economopoulos, T. (2008) Primary Extranodal Lymphomas of Stomach: Clinical Presentation, Diagnostic Pitfalls and Management. Annals of Oncology, 19, 1992-1999. https://doi.org/10.1093/annonc/mdn525
|
[3]
|
Sugita, S., Iijima, T., Furuya, S., et al. (2007) Gastric T-Cell Lymphoma with Cytotoxic Phenotype. Pathology International, 57, 108-114.
https://doi.org/10.1111/j.1440-1827.2006.02065.x
|
[4]
|
Wang, Y.G., Zhao, L.Y., Liu, C.Q., et al. (2016) Clinical Characteristics and Prognostic Factors of Primary Gastric Lymphoma: A Retrospective Study with 165 Cases. Medicine, 95, e4250. https://doi.org/10.1097/MD.0000000000004250
|
[5]
|
Li, M., Zhang, S., Gu, F., et al. (2014) Clinicopathological Characteristics and Prognostic Factors of Primary Gastrointestinal Lymphoma: A 22-Year Experience from South China. International Journal of Clinical and Experimental Pathology, 7, 2718-2728.
|
[6]
|
Malipatel, R., Patil, M., Rout, P., Correa, M. and Devarbhavi, H. (2018) Primary Gastric Lymphoma: Clinicopathological Profile. Euroasian Journal of Hepato-Gastroenterology, 8, 6-10. https://doi.org/10.5005/jp-journals-10018-1250
|
[7]
|
Zeggai, S., Harir, N., Tou, A., Medjamia, M. and Guenaoui, K. (2016) Gastrointestinal lymphoma in Western Algeria: Pattern of Distribution and Histological Subtypes (Retrospective Study). The Journal of Gastrointestinal Oncology, 7, 1011-1016.
https://doi.org/10.21037/jgo.2016.09.11
|
[8]
|
Wotherspoon, A.C., Doglioni, C., Diss, T.C., et al. (1993) Regression of Primary Low-Grade B-Cell Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type after Eradication of Helicobacter Pylori. The Lancet, 342, 575-577.
https://doi.org/10.1016/0140-6736(93)91409-F
|
[9]
|
Song, Y., Jiang, K., Su, S., Wang, B. and Chen, G. (2018) Clinical Manifestations and Epigenetic Mechanisms of Gastric Mucosa Associated Lymphoid Tissue Lymphoma and Long-Term Follow-Up Following Helicobacter Pylori Eradication. Experimental and Therapeutic Medicine, 15, 553-561. https://doi.org/10.3892/etm.2017.5413
|
[10]
|
Bai, Z. and Zhou, Y. (2021) A Systematic Review of Primary Gastric Diffuse Large B-Cell Lymphoma: Clinical Diagnosis, Staging, Treatment and Prognostic Factors. Leukemia Research, 111, Article ID: 106716.
https://doi.org/10.1016/j.leukres.2021.106716
|
[11]
|
Ferreri, A.J. and Montalbán, C. (2007) Primary Diffuse Large B-Cell Lymphoma of the Stomach. Critical Reviews in Oncology/Hematology, 63, 65-71.
https://doi.org/10.1016/j.critrevonc.2007.01.003
|
[12]
|
Willich, N.A., Reinartz, G., Horst, E.J., et al. (2000) Operative and Conservative Management of Primary Gastric Lymphoma: Interim Results of a German Multicenter Study. International Journal of Radiation Oncology, Biology, Physics, 46, 895-901. https://doi.org/10.1016/S0360-3016(99)00475-7
|
[13]
|
Koch, P., Probst, A., Berdel, W.E., et al. (2005) Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered within the German Multicenter Study (GIT NHL 02/96). Journal of Clinical Oncology, 23, 7050-7059.
https://doi.org/10.1200/JCO.2005.04.031
|
[14]
|
Thomas, A.S., Schwartz, M. and Quigley, E. (2019) Gastrointestinal Lymphoma: The New Mimic. BMJ Open Gastroenterology, 6, e000320.
https://doi.org/10.1136/bmjgast-2019-000320
|
[15]
|
Yoon, S.S., Coit, D.G., Portlock. C.S. and Karpeh, M.S. (2004) The Diminishing Role of Surgery in the Treatment of Gastric Lymphoma. Annals of Surgery, 240, 28-37. https://doi.org/10.1097/01.sla.0000129356.81281.0c
|
[16]
|
Shannon, E.M., MacQueen, I.T., Miller, J.M. and Maggard-Gibbons, M. (2016) Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: A Population-Based Survival Analysis. Journal of Gastrointestinal Surgery, 20, 1141-1149.
https://doi.org/10.1007/s11605-016-3129-8
|
[17]
|
Juárez-Salcedo, L.M., Sokol, L., Chavez, J.C. and Dalia, S. (2018) Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis and Treatment. Cancer Control, 25.
https://doi.org/10.1177/1073274818778256
|
[18]
|
Peng, J.C., Zhong, L. and Ran, Z.H. (2015) Primary Lymphomas in the Gastrointestinal Tract. Journal of Digestive Diseases, 16, 169-176.
https://doi.org/10.1111/1751-2980.12234
|
[19]
|
Wotherspoon, A.C., Ortiz-Hidalgo, C., Falzon, M.R. and Isaacson, P.G. (1991) Helicobacter Pylori-Associated Gastritis and Primary B-Cell Gastric Lymphoma. The Lancet, 338, 1175-1176. https://doi.org/10.1016/0140-6736(91)92035-Z
|
[20]
|
Engels, E.A. (2007) Infectious Agents as Causes of Non-Hodgkin Lymphoma. Cancer Epidemiology, Biomarkers & Prevention, 16, 401-404.
https://doi.org/10.1158/1055-9965.EPI-06-1056
|
[21]
|
Hirabayashi, M., Traverse-Glehen, A., Combes, J.D., Clifford, G.M. and de Martel, C. (2023) Estimating the Prevalence of Epstein-Barr Virus in Primary Gastric Lymphoma: A Systematic Review and Meta-Analysis. Infectious Agents and Cancer, 18, Article No. 8. https://doi.org/10.1186/s13027-023-00482-2
|
[22]
|
Engels, E.A., Cho, E.R. and Jee, S.H. (2010) Hepatitis B Virus Infection and Risk of Non-Hodgkin Lymphoma in South Korea: A Cohort Study. The Lancet Oncology, 11, 827-834. https://doi.org/10.1016/S1470-2045(10)70167-4
|
[23]
|
Ferrucci, P.F. and Zucca, E. (2007) Primary Gastric Lymphoma Pathogenesis and Treatment: What Has Changed over the Past 10 Years? British Journal of Haematology, 136, 521-538. https://doi.org/10.1111/j.1365-2141.2006.06444.x
|
[24]
|
Olszewska-Szopa, M. and Wróbel, T. (2019) Gastrointestinal Non-Hodgkin Lymphomas. Advances in Clinical and Experimental Medicine, 28, 1119-1124.
https://doi.org/10.17219/acem/94068
|
[25]
|
Tian, C., Li, Y. and Chen, Z. (2020) A Retrospective Analysis of Primary Gastrointestinal Non-Hodgkin Lymphomas: Clinical Features, Prognostic Factors and Treatment Outcomes. OncoTargets and Therapy, 13, 5345-5352.
https://doi.org/10.2147/OTT.S248381
|
[26]
|
Cui, Y., Sun, Z., Li, X., Leng, C., Zhang, L., Fu, X., Li, L., Zhang, X., Chang, Y.U., Nan, F., Li, Z., Yan, J., Zhang, M., Li, W., Wang, G., Zhang, D. and Ma, Y. (2016) Expression and Clinical Significance of Cyclooxygenase-2 and Interleukin-32 in Primary Gastric B-Cell Lymphoma. Oncology Letters, 11, 693-698.
https://doi.org/10.3892/ol.2015.3950
|
[27]
|
Vlăduţ, C., Ciocîrlan, M., Costache, R.S., Jinga, M., Balaban, V.D., Costache, D.O. and Diculescu, M. (2020) Is Mucosa-Associated Lymphoid Tissue Lymphoma an Infectious Disease? Role of Helicobacter Pylori and Eradication Antibiotic Therapy (Review). Experimental and Therapeutic Medicine, 20, 3546-3553.
https://doi.org/10.3892/etm.2020.9031
|
[28]
|
Andriani, A., Zullo, A., Di Raimondo, F., et al. (2006) Clinical and Endoscopic Presentation of Primary Gastric Lymphoma: A Multicentre Study. Alimentary Pharmacology & Therapeutics, 23, 721-726.
https://doi.org/10.1111/j.1365-2036.2006.02826.x
|
[29]
|
Al-Akwaa, A.M., Siddiqui, N. and Al-Mofleh, I.A. (2004) Primary Gastric Lymphoma. World Journal of Gastroenterology, 10, 5-11.
https://doi.org/10.3748/wjg.v10.i1.5
|
[30]
|
Ikoma, N., Badgwell, B.D. and Mansfield, P.F. (2017) Multimodality Treatment of Gastric Lymphoma. Surgical Clinics of North America, 97, 405-420.
https://doi.org/10.1016/j.suc.2016.11.012
|
[31]
|
Vetro, C., Chiarenza, A., Romano, A., Amico, I., Calafiore, V., Di Raimondo, C., Coppolino, F. and Di Raimondo, F. (2014) Prognostic Assessment and Treatment of Primary Gastric Lymphomas: How Endoscopic Ultrasonography Can Help in Tailoring Patient Management. Clinical Lymphoma, Myeloma and Leukemia, 14, 179-185. https://doi.org/10.1016/j.clml.2013.10.010
|
[32]
|
Wang, K.X., Ben, Q.W., Jin, Z.D., Du, Y.Q., Zou, D.W., Liao, Z. and Li, Z.S. (2011) Assessment of Morbidity and Mortality Associated with EUS-Guided FNA: A Systematic Review. Gastrointestinal Endoscopy, 73, 283-290.
https://doi.org/10.1016/j.gie.2010.10.045
|
[33]
|
Vetro, C., Romano, A., Amico, I., Conticello, C., Motta, G., Figuera, A., Chiarenza, A., Di Raimondo, C., Giulietti, G., Bonanno, G., Palumbo, G.A. and Di Raimondo, F. (2014) Endoscopic Features of Gastro-Intestinal Lymphomas: From Diagnosis to Follow-Up. World Journal of Gastroenterology, 20, 12993-13005.
https://doi.org/10.3748/wjg.v20.i36.12993
|
[34]
|
Schizas, D., Ntanasis-Stathopoulos, I., Tsilimigras, D.I., Sioulas, A.D., Moris, D., Spartalis, E., Scotiniotis, I. and Papanikolaou, I.S. (2017) The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma. Gastroenterology Research and Practice, 2017, Article ID: 2397430.
https://doi.org/10.1155/2017/2397430
|
[35]
|
Giovannini, M., Hookey, L.C., Bories, E., Pesenti, C., Monges, G. and Delpero, J.R. (2006) Endoscopic Ultrasound Elastography: The First Step towards Virtual Biopsy? Preliminary Results in 49 Patients. Endoscopy, 38, 344-348.
https://doi.org/10.1055/s-2006-925158
|
[36]
|
Hocke, M., Menges, M., Topalidis, T., Dietrich, C.F. and Stallmach, A. (2008) Contrast-Enhanced Endoscopic Ultrasound in Discrimination between Benign and Malignant Mediastinal and Abdominal Lymph Nodes. Journal of Cancer Research and Clinical Oncology, 134, 473-480. https://doi.org/10.1007/s00432-007-0309-7
|
[37]
|
Püspök, A., Raderer, M., Chott, A., Dragosics, B., Gangl, A. and Schöfl, R. (2002) Endoscopic Ultrasound in the Follow up and Response Assessment of Patients with Primary Gastric Lymphoma. Gut, 51, 691-694. https://doi.org/10.1136/gut.51.5.691
|
[38]
|
Ono, S., Kato, M., Ono, Y., Nishida, U., Yamamoto K., Shimizu, Y. and Asaka, M. (2011) Target Biopsy Using Magnifying Endoscopy in Clinical Management of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Journal of Gastroenterology and Hepatology, 26, 1133-1138.
https://doi.org/10.1111/j.1440-1746.2011.06729.x
|
[39]
|
Nonaka, K., Ishikawa, K., Arai, S., Nakao, M., Shimizu, M., Sakurai, T., Nagata, K., Nishimura, M., Togawa, O., Ochiai, Y., Sasaki, Y. and Kita, H. (2012) A Case of gastric Mucosa-Associated Lymphoid Tissue Lymphoma in which Magnified Endoscopy with Narrow Band Imaging Was Useful in the Diagnosis. World Journal of Gastrointestinal Endoscopy, 4, 151-156. https://doi.org/10.4253/wjge.v4.i4.151
|
[40]
|
Kav, T., Ozen, M., Uner, A., Abdullazade, S., Ozseker, B. and Bayraktar, Y. (2012) How Confocal Laser Endomicroscopy Can Help us in Diagnosing Gastric Lymphomas? Bratislava Medical Journal, 113, 680-682.
https://doi.org/10.4149/BLL_2012_155
|
[41]
|
Dolak, W., Kiesewetter, B., Müllauer, L., Mayerhoefer, M., Troch, M., Trauner, M., Häfner, M., Raderer, M. and Püspök, A. (2016) A Pilot Study of Confocal Laser Endomicroscopy for Diagnosing Gastrointestinal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Surgical Endoscopy, 30, 2879-2885.
https://doi.org/10.1007/s00464-015-4572-4
|
[42]
|
Isomoto, H., Matsushima, K., Hayashi, T., Imaizumi, Y., Shiota, J., Ishii, H., Minami, H., Ohnita, K., Takeshima, F., Shikuwa, S., Miyazaki, Y. and Nakao, K. (2013) Endocytoscopic Findings of Lymphomas of the Stomach. BMC Gastroenterology, 13, Article No. 174. https://doi.org/10.1186/1471-230X-13-174
|
[43]
|
Hodler, J., Kubik-Huch, R.A. and von Schulthess G.K. (Eds.) (2018) Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging-IDKD Book. Springer, Berlin.
https://doi.org/10.1007/978-3-319-75019-4
|
[44]
|
Byun, J.H., Ha, H.K., Kim, A.Y., Kim, T.K., Ko, E.Y., Lee, J.K., Yu, E.S., Myung, S.J., Yang, S.K., Jung, H.Y. and Kim, J.H. (2003) CT Findings in Peripheral T-Cell Lymphoma Involving the Gastrointestinal Tract. Radiology, 227, 59-67.
https://doi.org/10.1148/radiol.2271012129
|
[45]
|
Ma, Z., Fang, M., Huang, Y., He, L., Chen, X., Liang, C., Huang, X., Cheng, Z., Dong, D., Liang, C., Xie, J., Tian, J. and Liu, Z. (2017) CT-Based Radiomics Signature for Differentiating Borrmann Type IV Gastric Cancer from Primary Gastric Lymphoma. European Journal of Radiology, 91, 142-147.
https://doi.org/10.1016/j.ejrad.2017.04.007
|
[46]
|
Zeydanli, T. and Kilic, H.K. (2022) Performance of Quantitative CT Texture Analysis in Differentiation of Gastric Tumors. Japanese Journal of Radiology, 40, 56-65.
https://doi.org/10.1007/s11604-021-01181-x
|
[47]
|
Papaevangelou, E., Almeida, G.S., Jamin, Y., Robinson, S.P. and de Souza, N.M. (2015) Diffusion-Weighted MRI for Imaging Cell Death after Cytotoxic or Apoptosis-Inducing Therapy. British Journal of Cancer, 112, 1471-1479.
https://doi.org/10.1038/bjc.2015.134
|
[48]
|
Chou, C.K., Sheu, R.S., Yang, C.W., Wang, M.L. and Chen, L.T. (1994) Abdominal Pseudotumors and Simulated Lymphadenopathy in MRI: Differential Features with the Use of Retrograde Air Insufflation. Abdominal Radiology, 19, 503-506.
https://doi.org/10.1007/BF00198250
|
[49]
|
Avcu, S., Arslan, H., Unal, O., Kotan, C. and Izmirli, M. (2012) The Role of Diffusion-Weighted MR Imaging and ADC Values in the Diagnosis of Gastric Tumors. Journal of the Belgian Society of Radiology, 95, 1-5.
https://doi.org/10.5334/jbr-btr.62
|
[50]
|
Li, Qiong, Bai, R.-J. and Sun, H.-R. (2010) Application of MR DWI in Detection and Therapeutic Monitoring of Lymphoma. Chinese Journal of Medical Imaging Technology, 26, 2313-2316.
|
[51]
|
Perry, C., Herishanu, Y., Metzer, U., Bairey, O., Ruchlemer, R., Trejo, L., Naparstek, E., Sapir, E.E. and Polliack, A. (2007) Diagnostic Accuracy of PET/CT in Patients with Extranodal Marginal Zone MALT Lymphoma. European Journal of Haematology, 79, 205-209. https://doi.org/10.1111/j.1600-0609.2007.00895.x
|
[52]
|
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., Kim, S., Alavi, A. and Schuster, S.J. (2003) Utility of FDG-PET Scanning in Lymphoma by WHO Classification. Blood, 101, 3875-3876. https://doi.org/10.1182/blood-2002-09-2778
|
[53]
|
Alinari, L., Castellucci, P., Elstrom, R., Ambrosini, V., Stefoni, V., Nanni, C., Berkowitz, A., Tani, M., Farsad, M., Franchi, R., Fanti, S. and Zinzani, P.L. (2006) 18F-FDG PET in Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Leukemia & Lymphoma, 47, 2096-2101. https://doi.org/10.1080/10428190600733499
|
[54]
|
Hampson, F.A. and Shaw, A.S. (2008) Response Assessment in Lymphoma. Clinical Radiology, 63, 125-135. https://doi.org/10.1016/j.crad.2007.10.005
|
[55]
|
Ghimire, P., Wu, G.Y. and Zhu L. (2011) Primary Gastrointestinal lymphoma. World Journal of Gastroenterology, 17, 697-707.
https://doi.org/10.3748/wjg.v17.i6.697
|
[56]
|
Haug, A.R., Leisser, A., Wadsak, W., Mitterhauser, M., Pfaff, S., Kropf, S., Wester, H.J., Hacker, M., Hartenbach, M., Kiesewetter-Wiederkehr, B., Raderer, M. and Mayerhoefer, M.E. (2019) Prospective Non-Invasive Evaluation of CXCR4 Expression for the Diagnosis of MALT Lymphoma Using [68Ga] Ga-Pentixafor-PET/MRI. Theranostics, 9, 3653-3658. https://doi.org/10.7150/thno.31032
|
[57]
|
Mayerhoefer, M.E., Raderer, M., Lamm, W., Weber, M., Kiesewetter, B., Rohrbeck, J., Simonitsch-Klupp, I., Hacker, M., Leisser, A., Nics, L., Schmitl, S., Wester, H.J. and Haug, A. (2022) CXCR4 PET/MRI for Follow-Up of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma after First-Line Helicobacter Pylori Eradication. Blood, 139, 240-244. https://doi.org/10.1182/blood.2021013239
|
[58]
|
Duell, J., Krummenast, F., Schirbel, A., Klassen, P., Samnick, S., Rauert-Wunderlich, H., Rasche, L., Buck, A.K., Wester, H.J., Rosenwald, A., Einsele, H., Topp, M.S., Lapa, C. and Kircher, M. (2021) Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT. Journal of Nuclear Medicine, 62, 1415-1421. https://doi.org/10.2967/jnumed.120.257279
|
[59]
|
Sharma, P., Suman, S.K., Singh, H., Sharma, A., Bal, C., Malhotra, A. and Kumar, R. (2013) Primary Gastric Lymphoma: Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Detecting Relapse after Treatment. Leukemia & Lymphoma, 54, 951-958.
https://doi.org/10.3109/10428194.2012.717694
|
[60]
|
Giraudo, C., Raderer, M., Karanikas, G., Weber, M., Kiesewetter, B., Dolak, W., Simonitsch-Klupp, I. and Mayerhoefer, M.E. (2016) 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Investigative Radiology, 51,163-169. https://doi.org/10.1097/RLI.0000000000000218
|
[61]
|
Mayerhoefer, M.E., Prosch, H., Beer, L., Tamandl, D., Beyer, T., Hoeller, C., Berzaczy, D., Raderer, M., Preusser, M., Hochmair, M., Kiesewetter, B., Scheuba, C., Ba-Ssalamah, A., Karanikas, G., Kesselbacher, J., Prager, G., Dieckmann, K., Polterauer, S., Weber, M., Rausch, I., Brauner, B., Eidherr, H., Wadsak, W. and Haug, A.R. (2020) PET/MRI versus PET/CT in Oncology: A Prospective Single-Center Study of 330 Examinations Focusing on Implications for Patient Management and Cost Considerations. European Journal of Nuclear Medicine and Molecular Imaging, 47, 51-60. https://doi.org/10.1007/s00259-019-04452-y
|
[62]
|
Raderer, M., Kiesewetter, B. and Mayerhoefer, M.E. (2022) Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) vs. Gastroscopy: Can It Improve Detection of Extranodal Marginal Zone Lymphomas of the Stomach Following H. pylori Treatment? Expert Review of Hematology, 15, 565-571.
https://doi.org/10.1080/17474086.2022.2089110
|
[63]
|
Maconi, G., Radice, E., Bareggi, E. and Porro, G.B. (2009) Hydrosonography of the Gastrointestinal Tract. AJR: American Journal of Roentgenology, 193, 700-708.
https://doi.org/10.2214/AJR.08.1979
|
[64]
|
Braden, B., Ignee, A., Hocke, M., Palmer, R.M. and Dietrich, C. (2010) Diagnostic Value and Clinical Utility of Contrast Enhanced Ultrasound in Intestinal Diseases. Digestive and Liver Disease, 42, 667-674. https://doi.org/10.1016/j.dld.2010.05.018
|
[65]
|
Li, S., Huang, P., Wang, Z., Chen, J., Xu, H., Wang, L., Zhang, Y., Mo, G., Zhu, J. and Cosgrove, D. (2012) Preoperative T Staging of Advanced Gastric Cancer Using Double Contrast-Enhanced Ultrasound. Ultraschall in der Medizin, 33, E218-E224.
https://doi.org/10.1055/s-0032-1312958
|
[66]
|
Yan, C., Bao, X., Shentu, W., Chen, J., Liu, C., Ye, Q., Wang, L., Tan, Y. and Huang, P. (2016) Preoperative Gross Classification of Gastric Adenocarcinoma: Comparison of Double Contrast-Enhanced Ultrasound and Multi-Detector Row CT. Ultrasound in Medicine and Biology, 42, 1431-1440.
https://doi.org/10.1016/j.ultrasmedbio.2016.01.030
|
[67]
|
Liu, Z., Guo, J., Wang, S., Zhao, Y., Li, J., Ren, W., Tang, S., Xie, L., Huang, Y., Sun, S. and Huang, L. (2015) Evaluation of Transabdominal Ultrasound after Oral Administration of an Echoic Cellulose-Based Gastric Ultrasound Contrast Agent for Gastric Cancer. BMC Cancer, 15, Article No. 932.
https://doi.org/10.1186/s12885-015-1943-0
|
[68]
|
Shi, H., Yu, X.H., Guo, X.Z., Guo, Y., Zhang, H., Qian, B., Wei, Z.R., Li, L., Wang X.C. and Kong, Z.X. (2012) Double Contrast-Enhanced Two-Dimensional and Three-Dimensional Ultrasonography for Evaluation of Gastric Lesions. World Journal of Gastroenterology, 18, 4136-4144.
https://doi.org/10.3748/wjg.v18.i31.4136
|
[69]
|
Zhou, S.F., Yin, J.B., Yang, H., Zhong, J. and An, P. (2016) Application Value of Stomach Filling Ultrasonography and Intravenous Contrast Agents in Diagnosis of Advanced Gastric Cancer. European Review for Medical and Pharmacological Sciences, 20, 3206-3210.
|
[70]
|
Liu, L., Lu, D.-Y., Cai, J.-R. and Zhang, L. (2018) The Value of Oral Contrast Ultrasonography in the Diagnosis of Gastric Cancer in Elderly Patients. World Journal of Surgical Oncology, 16, Article No. 233. https://doi.org/10.1186/s12957-018-1527-y
|
[71]
|
Dietrich, C.F., Averkiou, M.A., Correas, J.M., Lassau, N., Leen, E. and Piscaglia. F. (2012) An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for Quantification of Tumour Perfusion. Ultraschall in der Medizin, 33, 344-351. https://doi.org/10.1055/s-0032-1313026
|
[72]
|
Lassau, N., Chebil, M., Chami, L., Bidault, S., Girard, E. and Roche, A. (2010) Dynamic Contrast-Enhanced Ultrasonography (DCE-US): A New Tool for the Early Evaluation of Antiangiogenic Treatment. Targeted Oncology, 5, 53-58.
https://doi.org/10.1007/s11523-010-0136-7
|
[73]
|
Lassau, N., Chami, L., Chebil, M., Benatsou, B., Bidault, S., Girard, E., Abboud, G. and Roche, A. (2011) Dynamic Contrast-Enhanced Ultrasonography (DCE-US) and Anti-Angiogenic Treatments. Discovery Medicine, 11, 18-24.
|
[74]
|
Albo, D., Granick, M.S., Jhala, N., Atkinson, B. and Solomon, M.P. (1994) The Relationship of Angiogenesis to Biological Activity in Human Squamous Cell Carcinomas of the Head and Neck. Annals of Plastic Surgery, 32, 588-594.
https://doi.org/10.1097/00000637-199406000-00005
|
[75]
|
Williams, J.K., Carlson, G.W., Cohen, C., Derose, P.B., Hunter, S. and Jurkiewicz, M.J. (1994) Tumor Angiogenesis as a Prognostic Factor in Oral Cavity Tumors. The American Journal of Surgery, 168, 373-380.
https://doi.org/10.1016/S0002-9610(05)80079-0
|
[76]
|
Zhuang, H., Yang, Z.G., Chen, H.J., Peng, Y.L. and Li, L. (2012) Time-Intensity Curve Parameters in Colorectal Tumours Measured Using Double Contrast-Enhanced Ultrasound: Correlations with Tumour Angiogenesis. Colorectal Disease, 14, 181-187.
https://doi.org/10.1111/j.1463-1318.2011.02546.x
|
[77]
|
Li, S.Y., Huang, P.T., Wang, Z.M., Huang, F.G., Zheng, Z.Q. and Yang, Y. (2009) The Relationship between Enhanced Intensity and Microvessel Density of Gastric Carcinoma Using Double Contrast-Enhanced Ultrasonography. Ultrasound in Medicine and Biology, 35, 1086-1091.
https://doi.org/10.1016/j.ultrasmedbio.2009.03.010
|
[78]
|
Lassau, N., Brule, A., Chami, L., Benatsou, B., Péronneau, P. and Roche, A. (2008) Evaluation précoce des traitements anti-angiogéniques par échographie dynamique de contraste. Journal de Radiologie, 89, 549-555. (In French)
https://doi.org/10.1016/S0221-0363(08)71480-X
|